Clinical Trials for Cue Biopharma

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Cue Biopharma

Clinical Trials (4)

NCT07172256
CUE-101with Pembrolizumab for LA-HPV+HNSCCs
PHASE2Not yet recruiting
30 participants
Started: Nov 30, 2025 · Completed: Nov 30, 2030
4 conditions3 sponsors1 location
NCT06917885
CUE-102 in Recurrent Glioblastoma
PHASE1Recruiting
18 participants
Started: Jul 30, 2025 · Completed: Jan 31, 2027
3 conditions2 sponsors2 locations
NCT04852328
Three Schedules of CUE-101 Administered Before Surgery or Definitive Chemoradiation Therapy in HLA-A*0201 Positive Patients With Locally Advanced, HPV16-Positive Oropharyngeal Squamous-Cell Carcinoma
PHASE2Recruiting
30 participants
Started: Dec 6, 2021 · Completed: Oct 31, 2027
1 condition2 sponsors1 location
NCT03978689
A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma
PHASE1Active, not recruiting
85 participants
Started: Jul 30, 2019 · Completed: Jan 31, 2026
3 conditions2 sponsors17 locations